ReCerf Achieves CE Mark, Enhancing Access to Hip Resurfacing Across Europe

ReCerf Achieves CE Mark for Enhanced Accessibility in Hip Resurfacing

On July 3, 2025, MatOrtho® proudly announced that its ReCerf® Hip Resurfacing Arthroplasty (HRA) has received the CE mark, affirming its compliance with European safety and performance standards. This significant milestone not only acknowledges the technical achievements over the last two decades but also paves the way for better accessibility of ceramic hip resurfacing treatments throughout the UK and across Europe.

Mike Tuke, founder of MatOrtho, emphasized the importance of this CE marking, stating, "It's not just a regulatory step; it represents two decades of focused efforts to enhance hip resurfacing using advanced materials." The breakthrough material, BIOLOX® delta, developed in collaboration with CeramTec A.G., has resulted in ReCerf – a ceramic-only resurfacing implant that already shows excellent clinical outcomes. This innovative product aims to assist surgeons who specialize in hip resurfacing and their patients who wish to remain active.

ReCerf stands out as the first commercially available ceramic HRA, having received initial approval from Australia's Therapeutic Goods Administration in November 2024. More than 1,600 patients have already benefited from this device since its introduction in 2018, with reported outcomes being highly positive and a very low revision rate observed even up to six years post-implantation.

Constructed from BIOLOX® delta ceramic, ReCerf effectively addresses the issues typically associated with metal-on-metal bearing surfaces and helps to preserve the patient's natural bone more effectively. For surgeons, the procedure remains familiar, bolstered by advanced materials, and supported by a company with a long-standing reputation in the field of modern hip resurfacing.

The CE mark's availability implies a strong commitment to responsible adoption of this innovative procedure. MatOrtho is actively promoting structured education, meticulous patient selection, and continued clinical monitoring. A peer-led surgical training program is already underway to ensure safe and effective utilization of ReCerf.

This achievement further solidifies MatOrtho's strategic growth and reaffirms its leadership in pioneering orthopedic solutions designed to restore joint function and support high levels of activity. To learn more, visit www.ReCerf.com.

About MatOrtho

MatOrtho (formerly Finsbury Orthopaedics) is a global leader in orthopedic invention and innovation, dedicated to advancing joint replacement technologies to improve patient outcomes and set new clinical standards. For additional information, visit www.matortho.com/recerf.